Fasting insulin concentrations and incidence of hypertension, stroke, and coronary heart disease: As meta-analysis of prospective cohort studies 1-3

American Journal of Clinical Nutrition

Volumn 98, Issue 6, 2013, Pages 1543-1554

  Xun, Pengcheng ^a   Wu, Ying ^b   He, Qianchuan ^c   He, Ka ^a  

^a INDIANA UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; DIET RESTRICTION; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; ISCHEMIC HEART DISEASE; META ANALYSIS;

COHORT STUDIES; CORONARY DISEASE; FASTING; HUMANS; HYPERINSULINISM; HYPERTENSION; INCIDENCE; INSULIN; INSULIN RESISTANCE; PROSPECTIVE STUDIES; RISK FACTORS; STROKE;

EID: 84888229840     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.113.065565     Document Type: Article

References (52)

1. Fernández-Real JM, Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 2003;24:278- 301.
2. Hildreth KL, Van Pelt RE, Schwartz RS. Obesity, insulin resistance, and Alzheimer's disease. Obesity (Silver Spring) 2012;20:1549-57.
3. Inoue M, Tsugane S. Insulin resistance and cancer: epidemiological evidence. Endocr Relat Cancer 2012;19:F1-8.
4. Ruige JB, Assendelft WJ, Dekker JM, Kostense PJ, Heine RJ, Bouter LM. Insulin and risk of cardiovascular disease: a meta- Analysis. Circulation 1998;97:996-1001.
5. Thuesen BH, Husemoen LL, Hersoug LG, Pisinger C, Linneberg A. Insulin resistance as a predictor of incident asthma-like symptoms in adults. Clin Exp Allergy 2009;39:700-7.
6. Laakso M. Cardiovascular disease in type 2 diabetes: challenge for treatment and prevention. J Intern Med 2001;249:225-35.
7. Onat A, Ceyhan K, Sansoy V, Basar O, Erer B, Uysal O, Hergenc G. Fasting insulin levels independently associated with coronary heart disease in non-diabetic Turkish men and women. Int J Cardiol 2002;86: 61-9.
8. Bataille V, Perret B, Troughton J, Amouyel P, Arveiler D, Woodside J, Dallongeville J, Haas B, Bingham A, Ducimetiere P, et al. Fasting insulin concentrations and coronary heart disease incidence in France and Northern Ireland: the PRIME Study. Int J Cardiol 2006;108:189-96.
9. Lempiäinen P, Mykkanen L, Pyorala K, Laakso M, Kuusisto J. Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men. Circulation 1999;100:123-8.
10. Pyörälä M, Miettinen H, Halonen P, Laakso M, Pyorala K. Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Arterioscler Thromb Vasc Biol 2000;20: 538-44.
11. Rundek T, Gardener H, Xu Q, Goldberg RB, Wright CB, Boden-Albala B, Disla N, Paik MC, Elkind MS, Sacco RL. Insulin resistance and risk of ischemic stroke among nondiabetic individuals from the northern Manhattan study. Arch Neurol 2010;67:1195-200.
12. Kronmal RA, Barzilay JI, Tracy RP, Savage PJ, Orchard TJ, Burke GL. The relationship of fasting serum radioimmune insulin levels to incident coronary heart disease in an insulin-treated diabetic cohort. J Clin Endocrinol Metab 2004;89:2852-8.
13. Chul Sung K, Lim S, Rosenson RS. Hyperinsulinemia and homeostasis model assessment of insulin resistance as predictors of hypertension: a 5-year follow-up study of Korean sample. Am J Hypertens 2011;24: 1041-5:.
14. Levin G, Kestenbaum B, Ida Chen YD, Jacobs DR Jr, Psaty BM, Rotter JI, Siscovick DS, de Boer IH. Glucose, insulin, and incident hypertension in the multi-ethnic study of atherosclerosis. Am J Epidemiol 2010;172:1144-54.
15. Lissner L, Bengtsson C, Lapidus L, Kristjansson K, Wedel H. Fasting insulin in relation to subsequent blood pressure changes and hypertension in women. Hypertension 1992;20:797-801.
16. Tsuruta M, Hashimoto R, Adachi H, Imaizumi T, Nomura G. Hyperinsulinaemia as a predictor of hypertension: an 11-year follow-up study in Japan. J Hypertens 1996;14:483-8.
17. Cheung BM, Wat NM, Man YB, Tam S, Cheng CH, Leung GM, Woo J, Janus ED, Lau CP, Lam TH, et al. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2). Am J Hypertens 2008;21:17-22.
18. He J, Klag MJ, Caballero B, Appel LJ, Charleston J, Whelton PK. Plasma insulin levels and incidence of hypertension in African Americans and whites. Arch Intern Med 1999;159:498-503.
19. Xun P, Liu K, Cao W, Sidney S, Williams OD, He K. Fasting insulin level is positively associated with incidence of hypertension among American young adults: a 20-year follow-up study. Diabetes Care 2012;35:1532-7.
20. Park SE, Rhee EJ, Park CY, Oh KW, Park SW, Kim SW, Lee WY. Impact of hyperinsulinemia on the development of hypertension in normotensive, nondiabetic adults: a 4-year follow-up study. Metabolism 2013;62:532-8.
21. Rasmussen-Torvik LJ, Yatsuya H, Selvin E, Alonso A, Folsom AR. Demographic and cardiovascular risk factors modify association of fasting insulin with incident coronary heart disease and ischemic stroke (from the Atherosclerosis Risk In Communities Study). Am J Cardiol 2010;105:1420-5.
22. Lawlor DA, Fraser A, Ebrahim S, Smith GD. Independent associations of fasting insulin, glucose, and glycated haemoglobin with stroke and coronary heart disease in older women. PLoS Med 2007;4:e263.
23. Møller LF, Jespersen J. Fasting serum insulin levels and coronary heart disease in a Danish cohort: 17-year follow-up. J Cardiovasc Risk 1995; 2:235-40.
24. Arima H, Kiyohara Y, Kato I, Tanizaki Y, Kubo M, Iwamoto H, Tanaka K, Abe I, Fujishima M. Alcohol reduces insulin- hypertension relationship in a general population: the Hisayama study. J Clin Epidemiol 2002;55:863-9.
25. Fagot-Campagna A, Balkau B, Simon D, Ducimetiere P, Eschwege E. Is insulin an independent risk factor for hypertension? The Paris Prospective Study. Int J Epidemiol 1997;26:542-50.
26. Wieberdink RG, Koudstaal PJ, Hofman A, Witteman JC, Breteler MM, Ikram MA. Insulin resistance and the risk of stroke and stroke subtypes in the nondiabetic elderly. Am J Epidemiol 2012;176:699-707.
27. Thacker EL, Psaty BM, McKnight B, Heckbert SR, Longstreth WT Jr, Mukamal KJ, Meigs JB, de Boer IH, Boyko EJ, Carnethon MR, et al. Fasting and post-glucose load measures of insulin resistance and risk of ischemic stroke in older adults. Stroke 2011;42:3347-51
28. Lakka HM, Lakka TA, Tuomilehto J, Sivenius J, Salonen JT. Hyperinsulinemia and the risk of cardiovascular death and acute coronary and cerebrovascular events in men: the Kuopio Ischaemic Heart Disease Risk Factor Study. Arch Intern Med 2000;160:1160-8.
29. Pyörälä M, Miettinen H, Laakso M, Pyorala K. Hyperinsulinemia and the risk of stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Stroke 1998;29:1860-6.
30. Wiberg B, Sundstrom J, Zethelius B, Lind L. Insulin sensitivity measured by the euglycaemic insulin clamp and proinsulin levels as predictors of stroke in elderly men. Diabetologia 2009;52:90-6.
31. Welin L, Eriksson H, Larsson B, Ohlson LO, Svardsudd K, Tibblin G. Hyperinsulinaemia is not a major coronary risk factor in elderly men. The study of men born in 1913. Diabetologia 1992;35:766-70
32. Yudkin JS, May M, Elwood P, Yarnell JW, Greenwood R, Davey Smith G. Concentrations of proinsulin like molecules predict coronary heart disease risk independently of insulin: prospective data from the Caerphilly Study. Diabetologia 2002;45:327-36.
33. Zethelius B, Byberg L, Hales CN, Lithell H, Berne C. Proinsulin is an independent predictor of coronary heart disease: Report from a 27-year follow-up study. Circulation 2002;105:2153-8.
34. Zethelius B, Lithell H, Hales CN, Berne C. Insulin sensitivity, proinsulin and insulin as predictors of coronary heart disease. A population- based 10-year, follow-up study in 70-year old men using the euglycaemic insulin clamp. Diabetologia 2005;48:862-7.
35. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535.
36. Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta- Analysis. Am J Epidemiol 1992;135:1301-9.
37. Duval S, Tweedie RA. Nonparametric "trim and fill" method of accounting for publication bias in meta-analysis. J Am Stat Assoc 2000; 95:89-98.
38. Denker PS, Pollock VE. Fasting serum insulin levels in essential hypertension. A meta-analysis. Arch Intern Med 1992;152:1649-51
39. Hu G, Qiao Q, Tuomilehto J, Eliasson M, Feskens EJ, Pyorala K. Plasma insulin and cardiovascular mortality in non-diabetic European men and women: a meta-analysis of data from eleven prospective studies. Diabetologia 2004;47:1245-56.
40. Sarwar N, Sattar N, Gudnason V, Danesh J. Circulating concentrations of insulin markers and coronary heart disease: a quantitative review of 19 Western prospective studies. Eur Heart J 2007;28:2491-7.
41. Gast KB, Tjeerdema N, Stijnen T, Smit JW, Dekkers OM. Insulin resistance and risk of incident cardiovascular events in adults without diabetes: meta-analysis. PLoS ONE 2012;7:e52036.
42. Rieker RP, Lee JC, Downing SE. Positive inotropic action of insulin on piglet heart. Yale J Biol Med 1975;48:353-60.
43. Liang C, Doherty JU, Faillace R, Maekawa K, Arnold S, Gavras H, Hood WB Jr. Insulin infusion in conscious dogs. Effects on systemic and coronary hemodynamics, regional blood flows, and plasma catecholamines. J Clin Invest 1982;69:1321-36.
44. Paulmyer-Lacroix O, Anglade G, Grino M. Insulin-induced hypoglycaemia increases colocalization of corticotrophin-releasing factor and arginine vasopressin mRNAs in the rat hypothalamic paraventricular nucleus. J Mol Endocrinol 1994;13:313-20.
45. Kageyama S, Yamamoto J, Isogai Y, Fujita T. Effect of insulin on sodium reabsorption in hypertensive patients. Am J Hypertens 1994;7 (5):409-15.
46. DeFronzo RA, Cooke CR, Andres R, Faloona GR, Davis PJ. The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. J Clin Invest 1975;55:845-55.
47. Ferri C, Pittoni V, Piccoli A, Laurenti O, Cassone MR, Bellini C, Properzi G, Valesini G, De Mattia G, Santucci A. Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo. J Clin Endocrinol Metab 1995;80:829-35.
48. Hu FB, Stampfer MJ. Insulin resistance and hypertension: the chickenegg question revisited. Circulation 2005;112:1678-80.
49. Barnard RJ, J, Roberts CK, Varon SM, Berger JJ. Diet-induced insulin resistance precedes other aspects of the metabolic syndrome. J Appl Physiol 1998;84:1311-5.
50. Brands MW, Hildebrandt DA, Mizelle HL, Hall JE. Sustained hyperinsulinemia increases arterial pressure in conscious rats. Am J Physiol 1991;260:R764-8.
51. Juan CC, Fang VS, Kwok CF, Perng JC, Chou YC, Ho LT. Exogenous hyperinsulinemia causes insulin resistance, hyperendothelinemia, and subsequent hypertension in rats. Metabolism 1999;48:465-71.
52. Ajjan R, Kearney MT, Grant PJ. Insulin resistance and the pathogenesis of cardiovascular disease. In: Zeitler PS, Nadeau KJ, eds. Insulin resistance: childhood precursors and adult disease. Clifton, NJ: Humana Press, 2008:179-205.